SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
4.630
-0.030 (-0.64%)
At close: Mar 20, 2026, 4:00 PM EDT
4.570
-0.060 (-1.30%)
After-hours: Mar 20, 2026, 7:51 PM EDT
SciSparc Employees
SciSparc had 2 employees as of December 31, 2024. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
$653,000
Profits / Employee
-$3,240,000
Market Cap
7.51M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 0 | - |
| Dec 31, 2021 | 3 | 1 | 50.00% |
| Dec 31, 2020 | 2 | -6 | -75.00% |
| Dec 31, 2019 | 8 | -3 | -27.27% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| CollPlant Biotechnologies | 57 |
| NuCana | 22 |
| BiomX | 20 |
| Cardio Diagnostics Holdings | 15 |
| Kiora Pharmaceuticals | 12 |
| Ernexa Therapeutics | 7 |
| Alzamend Neuro | 7 |
SPRC News
- 6 days ago - SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy - GlobeNewsWire
- 10 days ago - SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease - GlobeNewsWire
- 12 days ago - SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails - GlobeNewsWire
- 12 days ago - Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease - GlobeNewsWire
- 12 days ago - Neurothera Labs Inc. Announces Definitive Agreement To Acquire Majority Stake In Cliniquantum Ltd. - TheNewswire
- 20 days ago - SciSparc Announces 1-for-9 Reverse Share Split - GlobeNewsWire
- 6 weeks ago - SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA - GlobeNewsWire
- 6 weeks ago - Neurothera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA - TheNewswire